Difference between revisions of "NCCN guidelines"
Jump to navigation
Jump to search
m (→Fatigue) |
|||
| Line 27: | Line 27: | ||
**'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed] | **'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed] | ||
**'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0026 Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768886/ PubMed] | **'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0026 Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768886/ PubMed] | ||
| + | |||
| + | ==Distress Managtement= | ||
| + | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1431 NCCN Guidelines - Distress Management] | ||
==Geriatric Oncology== | ==Geriatric Oncology== | ||
*'''2012:''' Hurria et al. [https://doi.org/10.6004/Jnccn.2012.0019 Senior adult oncology.] [https://pubmed.ncbi.nlm.nih.gov/22308515/ PubMed] | *'''2012:''' Hurria et al. [https://doi.org/10.6004/Jnccn.2012.0019 Senior adult oncology.] [https://pubmed.ncbi.nlm.nih.gov/22308515/ PubMed] | ||
| − | *'''2005:''' Balducci et al. [https://doi.org/10.6004/Jnccn.2005.0032 Senior adult oncology clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038647/ PubMed] | + | **'''2005:''' Balducci et al. [https://doi.org/10.6004/Jnccn.2005.0032 Senior adult oncology clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038647/ PubMed] |
==Middle East and North Africa== | ==Middle East and North Africa== | ||
Revision as of 11:24, 7 May 2024
This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
Guidelines
AYA
Bone Health
- 2009: Gralow et al. NCCN Task Force Report: Bone Health in Cancer Care. PubMed
Cancer Screening
- NCCN Guidelines - Breast Cancer Screening and Diagnosis
- 2018: Bevers et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2009: Bevers et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. PubMed
- 2003: Authors not listed. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. PubMed
- 2016: Williams et al. Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. PubMed
- 2010: Burt et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. PubMed
Cancer Related Infections
- 2016: Baden et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2012: Baden et al. Prevention and treatment of cancer-related infections. PubMed
- 2008: Segal et al. Prevention and treatment of cancer-related infections. PubMed
Cancer Risk Reduction
- 2016: Shields et al. Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. PubMed
- NCCN Guidelines - Breast Cancer Risk Reduction
- 2015: Bevers et al. Breast Cancer Risk Reduction, Version 2.2015. PubMed
- 2003: Authors not listed. Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. PubMed
=Distress Managtement
Geriatric Oncology
- 2012: Hurria et al. Senior adult oncology. PubMed
- 2005: Balducci et al. Senior adult oncology clinical practice guidelines in oncology. PubMed
Middle East and North Africa
- 2010: Abulkhair et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. PubMed
- 2010: Içli et al. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. PubMed
- 2010: Yusuf et al. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. PubMed
- 2010: Bazarbachi et al. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. PubMed
- 2010: Jazieh et al. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. PubMed
- 2010: Shamieh et al. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region. PubMed
- 2010: Hassen et al. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. PubMed
Myeloid Growth Factor
- 2013: Crawford et al. Myeloid growth factors. PubMed
- 2011: Crawford et al. Myeloid growth factors. PubMed
- 2009: Crawford et al. Myeloid growth factors. PubMed
- 2007: Crawford et al. Myeloid growth factors. Clinical practice guidelines in oncology. PubMed
- 2005: Crawford et al. Myeloid growth factors clinical practice guidelines in oncology. PubMed
Palliative Care
- 2009: Levy et al. NCCN clinical practice guidelines in oncology: palliative care. PubMed
Survivorship
- 2017: Denlinger et al. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2014: Denlinger et al. Survivorship: healthy lifestyles, version 2.2014. PubMed
- 2014: Denlinger et al. Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. PubMed
- 2014: Denlinger et al. Survivorship: pain version 1.2014. PubMed
- 2014: Denlinger et al. Survivorship: sexual dysfunction (female), version 1.2013. PubMed
- 2014: Denlinger et al. Survivorship: sexual dysfunction (male), version 1.2013. PubMed
- 2014: Denlinger et al. Survivorship: sleep disorders, version 1.2014. PubMed